Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Small Molecules of Lactoferrin Modification by Ionic Liquids Against SARS-CoV-2: Molecular Docking Enhanced the Results

Version 1 : Received: 2 February 2024 / Approved: 5 February 2024 / Online: 5 February 2024 (05:36:49 CET)

How to cite: Senan, A.M.; Muhammed, M.T.; Akkoc, S.; Alhag, S.K.; A.Al-Shahari, E.; Al-Shuraym, L.A.; Alsudays, I.M.; AKTAŞ, A.H. Small Molecules of Lactoferrin Modification by Ionic Liquids Against SARS-CoV-2: Molecular Docking Enhanced the Results. Preprints 2024, 2024020221. https://doi.org/10.20944/preprints202402.0221.v1 Senan, A.M.; Muhammed, M.T.; Akkoc, S.; Alhag, S.K.; A.Al-Shahari, E.; Al-Shuraym, L.A.; Alsudays, I.M.; AKTAŞ, A.H. Small Molecules of Lactoferrin Modification by Ionic Liquids Against SARS-CoV-2: Molecular Docking Enhanced the Results. Preprints 2024, 2024020221. https://doi.org/10.20944/preprints202402.0221.v1

Abstract

Ionic liquid MIE-NH2 displays a new role of development of modification of glycoproteins of lactoferrin through a reductive amination mechanism to synthesize versatile pharmaceuticals. This work introduces a new strategy of modification of Lactoferrin by using methylimidazolium N-ethylamine, this ionic liquid MIE-NH2 linked to N-glycans in Lactoferrin derivatives. Using UPLC/ESI-QTOF and MALDI-TOF mass spectrometry to perform and detect the modifying of ionic liquid-linked glycoproteins. Relevantly, modifying the lactoferrin by MIE-H2 as a small molecule of ion liquid lactoferrin (IL-Lf), which could be a potential antiviral drug and it is achieved by inhibiting various targets. The probability of the lactoferrin modified as a small IL-Lf-molecule to inhibit any of these targets was investigated to find out its potency as a SARS-CoV-2 inhibitor. Molecular docking disclosed the activity of modifying glycoproteins - small IL-Lf-molecules containing amino groups and interaction with targeted Mpro, RdRp, TMPRSS2, and PLpro. Clinically, this study shows the a volubility to provide small IL-Lf-molecules as significantly important drugs that target main protease (Mpro), RNA dependent RNA polymerase (RdRp), transmembrane protease serine 2 (TMPRSS2), and Papain-like protease (PLpro).

Keywords

ionic liquid; infections; lactoferrin; N-glycans; mass spectrophotometry

Subject

Medicine and Pharmacology, Epidemiology and Infectious Diseases

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.